Abstract
Background To analyze retrospectively the results of treatments for patients with brain metastases from breast cancer. Materials and Methods The records of 65 breast cancer patients with brain metastases who were treated between 1985 and 2005 were reviewed. For brain metastases, 11 patients (17%) were treated with surgical resection followed by radiotherapy, and the remaining 54 patients were treated with radiotherapy alone. Systemic chemotherapy was also administered to 11 patients after brain radiotherapy. Results The overall median survival for all patients was 6.1 months (range, 0.4–82.2 months). In univariate analysis, treatment modality, Karnofsky performance status (KPS), administration of systemic chemotherapy, extracranial disease status and total radiation dose each had significant impact on overall survival, and in multivariate analysis, treatment modality, KPS and administration of systemic chemotherapy were significant prognostic factors. Eight patients survived for more than 2 years after the diagnosis of brain metastases, and all these patients were treated with surgical resection and/or systemic chemotherapy in addition to radiotherapy. For the 45 patients treated with palliative radiotherapy (without systemic chemotherapy), the improvements in neurological symptoms were observed in 35 patients (78%), with the median duration of improvement of 3.1 months (range, 1.5–4.4 months). Conclusions The prognoses for patients with brain metastases from breast cancer were generally poor, although selected patients may survive longer with intensive brain tumor treatment, such as surgical resection and/or systemic chemotherapy in addition to brain radiotherapy. For patients with unfavorable prognoses, palliative radiotherapy was effective in improving the quality of the remaining lifetime.
Similar content being viewed by others
References
Loeffler JS, Patchell RA, Sawata R (1997) Metastatic brain tumor. In: Devita VT Jr, Hellman S, Rosenberg SA (eds) Cancer: principles and practice of oncology, 5th edn. Lippincott-Raven, Philadelphia, pp 2523–2536
Phillips TL, Scott CB, Leibel SA et al (1995) Results of a randomized comparison of radiotherapy and bromodeoxyuridine with radiotherapy alone for brain metastases: report of RTOG trial 89–05. Int J Radiat Oncol Biol Phys 33:339–348
Borgelt B, Gelber R, Kramer S et al (1980) The palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 6:1–9
Lee YT (1983) Breast carcinoma: pattern of metastasis at autopsy. J Surg Oncol 23:175–180
DiStefano A, Yong Yap Y, Hortobagyi GN et al (1979) The natural history of breast cancer patients with brain metastases. Cancer 44:1913–1918
Chang EL, Lo S (2003) Diagnosis and management of central nervous system metastases from breast cancer. Oncologist 8:398–410
Patchell RA, Tibbs PA, Walsh JW et al (1990) A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 322:494–500
Zimm S, Wampler GL, Stablein D et al (1981) Intracerebral metastases in solid-tumor patients: natural history and results of treatment. Cancer 48:384–394
Gaspar L, Scott C, Rotman M et al (1997) Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 37:745–751
Kaplan EL, Meier P (1985) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457–481
Mantel N (1966) Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163–170
Cox DR (1972) Regression models and life tables. J R Stat Soc 34:187–220
Agboola O, Benoit B, Cross P et al (1998) Prognostic factors derived from recursive partition analysis (RPA) of Radiation Therapy Oncology Group (RTOG) brain metastases trials applied to surgically resected and irradiated brain metastatic cases. Int J Radiat Oncol Biol Phys 42:155–159
Gaspar LE, Scott C, Murray K et al (2000) Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases. Int J Radiat Oncol Biol Phys 47:1001–1006
Yamada K, Murakami M, Kuroda Y (1997) Treatment results of brain metastases from breast cancer: course of the disease and radiation therapy. Nippon Igaku Hoshasen Gakkai Zasshi 57:34–40 (in Japanese)
Boogerd W (1996) Central nervous system metastases in breast cancer. Radiother Oncol 40:5–22
Wronski M, Arbit E, McCormick B (1997) Surgical treatment of 70 patients with brain metastases from breast carcinoma. Cancer 80:1746–1754
Vecht CJ, Haaxma-Reiche H, Noordijk EM et al (1993) Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery? Ann Neurol 33:583–590
Breneman JC, Warnick RE, Albright RE et al (1997) Stereotactic ardiosurgery for the treatment of brain metastases. Results of a single institution series. Cancer 79:551–557
Adler JR, Cox RS, Kaplan I et al (1992) Stereotactic radiosurgical treatment of brain metastases. J Neurosurg 76:444–449
Saito EY, Viani GA, Ferrigno R et al (2006) Whole brain radiation therapy in management of brain metastasis: results and prognostic factors. Radiat Oncol 1:20
Workman P (1986) The pharmacology of brain tumour chemotherapy. In: Bleehen NM (ed) Tumours of the brain. Springer-Verlag, Berlin, pp 183–200
Greig NH (1989) Brain tumors and the blood-brain barrier. In: Neuwelt EA (ed) Implications of the blood–brain barrier and its manipulation, Vol 2. Plenum, New York, pp 77–106
Fortin D, Gendron C, Boudrias M et al (2007) Enhanced chemotherapy delivery by intraarterial infusion and blood–brain barrier disruption in the treatment of cerebral metastasis. Cancer 109:751–760
Rosner D, Nemoto T, Lane WW (1986) Chemotherapy induces regression of brain metastases in breast carcinoma. Cancer 58:832–839
Bartsch R, Fromm S, Rudas M et al (2006) Intensified local treatment and systemic therapy significantly increase survival in patients with brain metastases from advanced breast cancer-a retrospective analysis. Radiother Oncol 80:313–317
Boogerd W, Dalesio O, Bais EM et al (1992) Response of brain metastases from breast cancer to systemic chemotherapy. Cancer 69:972–980
Boogerd W, Vos VW, Hart AAM et al (1993) Brain metastases in breast cancer; natural history, prognostic factors and outcome. J Neurooncol 15:165–174
Colleoni M, Graiff C, Nelli P et al (1997) Activity of combination chemotherapy in brain metastases from breast and lung adenocarcinoma. Am J Clin Oncol 20:303–307
Snee MP, Rodger A, Kerr GR (1985) Brain metastases from carcinoma of breast: a review of 90 cases. Clin Radiol 36:365–367
Ogura M, Mitsumori M, Okumura S et al (2003) Radiation therapy for brain metastases from breast cancer. Breast Cancer 10:349–355
Lentzsch S, Reichardt P, Weber F et al (1999) Brain metastases in breast cancer: prognostic factors and management. Eur J Cancer 35:580–585
Mahmoud-Ahmed AS, Suh JH, Lee SY et al (2002) Results of whole brain radiotherapy in patients with brain metastases from breast cancer: a retrospective study. Int J Radiat Oncol Biol Phys 54:810–817
Le Scodan R, Massard C, Mouret-Fourme E et al (2007) Brain metastases from breast carcinoma: validation of the Radiation Therapy Oncology Group recursive partitioning analysis classification and proposition of a new prognostic score. Int J Radiat Oncol Biol Phys doi: 10.1016/j.irobp.2007.04.024
Kocher M, Muller RP, Staar S et al (1995) Long-term survival after brain metastases in breast cancer. Strahlenther Onkol 171:290–295
Kurtz JM, Gelber R, Brady LW et al (1981) The palliation of brain metastases in a favorable patient population: a randomized clinical trial by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 7:891–895
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ogawa, K., Yoshii, Y., Nishimaki, T. et al. Treatment and prognosis of brain metastases from breast cancer. J Neurooncol 86, 231–238 (2008). https://doi.org/10.1007/s11060-007-9469-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-007-9469-1